US Patent Issued to The Schepens Eye Research Institute on July 7 for "Methods and materials for treatment of fibrosis" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,063, issued on July 7, was assigned to The Schepens Eye Research Institute Inc. (Boston).

"Methods and materials for treatment of fibrosis" was invented by Joseph F. Arboleda-Velasquez (Newton, Mass.) and Leo A. Kim (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods for treating and reducing risk of fibrosis, e.g., pulmonary fibrosis, in a subject by administering an inhibitor of RUNX family transcription factor 1 (RUNX1) or core-binding factor subunit beta (CBFBeta), e.g., in a subject who has a viral infection."

The patent was filed on April 16, 2021, under Application No. 17/920,502.

*For further information, inc...